| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 01/16/2003 | WO2002029030A3 Ethanol production |
| 01/16/2003 | WO2002029026A3 Human proteases and polynucleotides encoding the same |
| 01/16/2003 | WO2002029018A3 Divinyl ether synthase gene and protein, and uses thereof |
| 01/16/2003 | WO2002026782A3 Antiangiogenic polypeptides and methods for inhibiting angiogenesis |
| 01/16/2003 | WO2002022806A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 01/16/2003 | WO2002020813A3 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 01/16/2003 | WO2002016616A3 Human carboxylesterase family member and uses thereof |
| 01/16/2003 | WO2002010406A3 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 01/16/2003 | WO2002008403A3 Nucleic acid sequences encoding beta-ketoacyl-acp synthase and uses thereof |
| 01/16/2003 | WO2002006465A3 7677, a novel human atpase family member and uses therefor |
| 01/16/2003 | WO2002006443A3 Lipoxygenase-inducible promoter, expression cassettes comprising same and transformed plants |
| 01/16/2003 | WO2001092490A3 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 01/16/2003 | WO2001091739A3 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 01/16/2003 | WO2001090326A3 Novel matrix metalloproteinases |
| 01/16/2003 | WO2001068880A9 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 01/16/2003 | WO2001068806A9 26934, a novel cytidine deaminase-like molecule and uses thereof |
| 01/16/2003 | WO2001064944A9 MODULATION OF PLEIOTROPHIN SIGNALING BY RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE β/$g(z) |
| 01/16/2003 | WO2001064913A9 Cell cycle proteins associated with rad9, compositions and methods of use |
| 01/16/2003 | WO2001055443A9 Crystallization and structure determination of staphylococcus aureus nad synthetase |
| 01/16/2003 | WO2001055409A9 Microbes and methods for remediation |
| 01/16/2003 | US20030014775 Compositions and method for modulation of gene expression in plants |
| 01/16/2003 | US20030014774 Transgenic rice plant and its family with environmental stress resistant by proline accumulation of high level and its production |
| 01/16/2003 | US20030014772 Transgenic mice containing MSK2 serine/threonine kinase gene disruptions |
| 01/16/2003 | US20030014771 Transgenic mice containing USP3-like deubiquitinating enzyme gene disruptions |
| 01/16/2003 | US20030014770 Alpha (1,3) galactosyl transferase negative swine |
| 01/16/2003 | US20030014192 Crystal structure |
| 01/16/2003 | US20030013857 Crosslinking and immobilizing biomolecules, drugs and synthetic polymers with a thiol or amino reactive group and hydrazino or oxyamino moieties |
| 01/16/2003 | US20030013855 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013853 Polypeptide for the treatment of gastrointestinal and neoplastic disorders |
| 01/16/2003 | US20030013848 Protein-tyrosine kinase genes |
| 01/16/2003 | US20030013707 Enzyme inhibitor |
| 01/16/2003 | US20030013673 Modulation activity by administering mutant polypeptide; controlling apoptosis |
| 01/16/2003 | US20030013649 Hybrid polypeptide |
| 01/16/2003 | US20030013636 Prevent biosynthesis of galactoside |
| 01/16/2003 | US20030013181 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
| 01/16/2003 | US20030013180 Pullulanase for use in saccharfication of stsrches |
| 01/16/2003 | US20030013179 Enzymatic polypeptide for use in the treatment of lysosomal storage disorders |
| 01/16/2003 | US20030013178 DNA sequence surrounding the glucocerebrosidase gene |
| 01/16/2003 | US20030013177 Polynucleotides encoding insect glutaminyl cyclase and uses thereof |
| 01/16/2003 | US20030013176 Enzymatic crystal of preferential protein for use in evaluating inhibitor binding activity |
| 01/16/2003 | US20030013175 Enzymatic polypetide for use in modifying carbohydrates |
| 01/16/2003 | US20030013174 Genes for lysine biosynthetic system derived from thermophilic bacteria |
| 01/16/2003 | US20030013173 UDP-galactose: beta-N-acetyl-glucosamine beta-1,4-galactosyltransferase, beta4Gal-T2 |
| 01/16/2003 | US20030013172 Purification of preferential enzyme from culture; generate nutrient broth, inoculate broth with genetically engineered bacteria, express vector, filter and recover enzyme |
| 01/16/2003 | US20030013170 Inhibitors of receptor activator of NF-kappaB and uses thereof |
| 01/16/2003 | US20030013168 Peptide for use in human therapeutics and diagnostic compositions |
| 01/16/2003 | US20030013167 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 01/16/2003 | US20030013165 Hydrolytic process of oil and fat |
| 01/16/2003 | US20030013153 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013150 Methods for large scale protein production in prokaryotes |
| 01/16/2003 | US20030013108 Novel RIP3 associated cell cycle proteins, compositions and methods of use |
| 01/16/2003 | US20030013102 D-hydantoinase from Ochrobactrum anthropi |
| 01/16/2003 | US20030013098 Detection of preferential nucleotide sequences in sample; obtain sample, expose to endonuclease, incubate with oligonucleotides, detect cleavage products |
| 01/16/2003 | US20030013095 Nuclcic acid enzyme for use in the prevention and treatment of infections and cancer |
| 01/16/2003 | US20030013090 Methods of diagnosing multidrug resistant tuberculosis |
| 01/16/2003 | US20030012819 Method of preparing biological materials and preparations produced using same |
| 01/16/2003 | US20030012778 Reversibly inactivated acidified plasmin |
| 01/16/2003 | US20030012777 Polymer conjugates of proteinases |
| 01/16/2003 | CA2453195A1 Sir2 activity |
| 01/16/2003 | CA2453173A1 Mycobacterial antigens expressed during latency |
| 01/16/2003 | CA2453075A1 Drug metabolizing enzymes |
| 01/16/2003 | CA2452366A1 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis |
| 01/16/2003 | CA2452359A1 Expression vectors encoding bacteriophage signal peptides |
| 01/16/2003 | CA2451374A1 Aggrecanase molecules |
| 01/16/2003 | CA2450867A1 Method of modifying enzyme and oxidoreductase variant |
| 01/16/2003 | CA2450256A1 Catalase-inactivating compounds and the use thereof |
| 01/16/2003 | CA2450185A1 Use of a tyrosine recombinase for genetic engineering |
| 01/15/2003 | EP1275733A2 Assay methods for peptidase modulators |
| 01/15/2003 | EP1275729A1 Process for producing l-amino acid via fermentation method |
| 01/15/2003 | EP1275728A1 Polyhydroxyalkanoate-containing structure and manufacturing method thereof |
| 01/15/2003 | EP1275723A1 Recombinant D-hydantoin hydrolases and N-carbamyl-D-amino acid hydrolases, and DNA encoding them; uses thereof for producing D-amino acids |
| 01/15/2003 | EP1275722A1 A P387L variant in protein tyrosine phosphatase-1B is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro |
| 01/15/2003 | EP1275721A1 Alpha 1,4-n-acetylgalactosamine transferase gene and process for producing this enzyme and n-acetylgalactosamine-containing complex carbohydrate |
| 01/15/2003 | EP1275720A2 Histidyl-trna synthetase of staphylococcus aureus |
| 01/15/2003 | EP1275714A1 Alpha 1,2-fucosyltransferase and process for producing fucose-containing complex carbohydrate |
| 01/15/2003 | EP1275712A2 Detergents comprising cellulases |
| 01/15/2003 | EP1275711A1 Lipase/acyltransferase from Candida parapsilosis |
| 01/15/2003 | EP1274980A1 Solution and crystal structures of mmp-13 active site and uses thereof |
| 01/15/2003 | EP1274859A1 Specific peptide substrate for human yak1, yak3a, and yak3b and yeast yak1 protein kinases |
| 01/15/2003 | EP1274856A1 Fungal lactate dehydrogenase gene and constructs for the expression thereof |
| 01/15/2003 | EP1274854A2 Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same |
| 01/15/2003 | EP1274853A1 Materials and methods relating to immune responses to fusion proteins |
| 01/15/2003 | EP1274850A2 Nucleic acid sequences to proteins involved in tocopherol synthesis |
| 01/15/2003 | EP1274849A2 Protein phosphatases |
| 01/15/2003 | EP1274848A2 Mre11 orthologue and uses thereof |
| 01/15/2003 | EP1274847A1 Sham-sensitive terminal oxidase gene from xylose-fermenting yeast |
| 01/15/2003 | EP1274836A1 Lactic acid bacteria overproducing exopolysaccharides |
| 01/15/2003 | EP1274835A1 Human nim1 kinase |
| 01/15/2003 | EP1274834A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2003 | EP1274732A1 Secretory tyrosine phosphatases from mycobacteria |
| 01/15/2003 | EP1274720A1 Albumin fusion proteins |
| 01/15/2003 | EP1274719A2 Albumin fusion proteins |
| 01/15/2003 | EP1015627A4 Method for detecting a target compound using a nucleic acid ligand |
| 01/15/2003 | EP0781349B1 Decomposition of bacteria cells by phage lysins |
| 01/15/2003 | CN1391612A Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium |
| 01/15/2003 | CN1391611A Novel phenol oxidizing enzymes |
| 01/15/2003 | CN1391606A Mimic cellulose binding domain |
| 01/15/2003 | CN1391579A HEV antigenic peptide and its method |
| 01/15/2003 | CN1391479A Medicament for inducing tolerance |
| 01/15/2003 | CN1390945A Microorgan to produce fructose transferase and fructose oligosaccharlde thereby and process thereof |